Public-registry site landscape for NCT06175221, a Tumor, Solid study sponsored by Elios Therapeutics, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06175221 (registry record) |
| Sponsor | Elios Therapeutics, LLC |
| Condition(s) | Tumor, Solid; Tumor Metastasis; Cancer; Tumor |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06175221 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →